EUVIMEDEUVIMED entdecken
Crossref

Subclinical minute FLT3 ‐ITD clone can be detected in clinically FLT3 ‐ ITD‐negative acute myeloid leukaemia at diagnosis

Shota Yokoyama, Masahiro Onozawa iD, Shota Yoshida, Naoki Miyashita, Hiroyuki Kimura, Shogo Takahashi, Toshihiro Matsukawa, Hideki Goto, Shinichi Fujisawa, Kosuke Miki, Daisuke Hidaka, Junichi Hashiguchi und 12 weitere

British Journal of Haematology · 2023-06 · 201 (6) · 1144-1152

DOI: 10.1111/bjh.18800 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 17.04.2023. Verfasst von Shota Yokoyama und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent advances in next‐generation sequencing (NGS) have enabled the detection of subclinical minute FLT3 ‐ITD. We selected 74 newly diagnosed, cytogenetically normal acute myeloid leukaemia (AML) samples in which FLT3 ‐ITD was not detected by gel electrophoresis. We sequenced them using NGS and found minute FLT3 ‐ITDs in 19 cases. We compared cases with clinically relevant FLT3 ‐ITD ( n = 37), cases with minute FLT3 ‐ITD ( n = 19) and cases without detectable FLT3 ‐ITD ( n = 55). Molecular characteristics (location and length) of minute FLT3 ‐ITD were similar to those of clinically relevant FLT3 ‐ITD. Survival of cases with minute FLT3 ‐ITD was similar to that of cases without detectable FLT3 ‐ITD, whereas the relapse rate within 1 year after onset was significantly higher in cases with minute FLT3 ‐ITD. We followed 18 relapsed samples of cases with clinically FLT3 ‐ITD‐negative at diagnosis. Two of 3 cases with minute FLT3 ‐ITD relapsed with progression to clinically relevant FLT3 ‐ITD. Two of 15 cases in which FLT3 ‐ITD was not detected by NGS relapsed with the emergence of minute FLT3 ‐ITD, and one of them showed progression to clinically relevant FLT3 ‐ITD at the second relapse. We revealed the clonal dynamics of subclinical minute FLT3 ‐ITD in clinically FLT3 ‐ITD‐negative AML. Minute FLT3 ‐ITD at the initial AML can expand to become a dominant clone at relapse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasm Recurrence, LocalLeukemia, Myeloid, AcuteHumansHigh-Throughput Nucleotide Sequencingfms-Like Tyrosine Kinase 3MutationPrognosis

Stichwörter der Autor:innen

Hokkaido Leukemia Net (HLN)acute myeloid leukaemia (AML)clonal diversityminute FLT3-ITDnext-generation sequencing (NGS)relapse

Substanzen

fms-Like Tyrosine Kinase 3FLT3 protein, human

Autor:innen und Institutionen

  • Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan.
  • Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.
  • Department of Hematology, Teine Keijinkai Hospital, Sapporo, Japan.
  • Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
  • Department of Hematology, Kitami Red Cross Hospital, Kitami, Japan.
  • Division of Hematology, Obihiro-Kosei General Hospital, Obihiro, Japan.

ORCID-Profile: Masahiro Onozawa, Akio Mori

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Yokoyama, S., Onozawa, M., Yoshida, S., Miyashita, N., Kimura, H., Takahashi, S., Matsukawa, T., Goto, H., Fujisawa, S., Miki, K., Hidaka, D., Hashiguchi, J., Wakasa, K., Ibata, M., Takeda, Y., Shigematsu, A., Fujimoto, K., Tsutsumi, Y., Mori, A., …, & Teshima, T. (2023). Subclinical minute FLT3 ‐ITD clone can be detected in clinically FLT3 ‐ ITD‐negative acute myeloid leukaemia at diagnosis. British Journal of Haematology, 201(6), 1144-1152. https://doi.org/10.1111/bjh.18800

Vancouver

Yokoyama S, Onozawa M, Yoshida S, Miyashita N, Kimura H, Takahashi S, et al. Subclinical minute FLT3 ‐ITD clone can be detected in clinically FLT3 ‐ ITD‐negative acute myeloid leukaemia at diagnosis. British Journal of Haematology. 2023;201(6):1144-1152. doi:10.1111/bjh.18800

BibTeX
@article{Yokoyama2023,
  author = {Yokoyama, Shota and Onozawa, Masahiro and Yoshida, Shota and Miyashita, Naoki and Kimura, Hiroyuki and Takahashi, Shogo and Matsukawa, Toshihiro and Goto, Hideki and Fujisawa, Shinichi and Miki, Kosuke and Hidaka, Daisuke and Hashiguchi, Junichi and Wakasa, Kentaro and Ibata, Makoto and Takeda, Yukari and Shigematsu, Akio and Fujimoto, Katsuya and Tsutsumi, Yutaka and Mori, Akio and Ishihara, Toshimichi and Kakinoki, Yasutaka and Kondo, Takeshi and Hashimoto, Daigo and Teshima, Takanori},
  title = {Subclinical minute FLT3 ‐ITD clone can be detected in clinically FLT3 ‐ ITD‐negative acute myeloid leukaemia at diagnosis},
  journal = {British Journal of Haematology},
  year = {2023},
  volume = {201},
  number = {6},
  pages = {1144--1152},
  doi = {10.1111/bjh.18800}
}
Kostenlos starten →